Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion

Diabetes

Volumn 46, Issue 1, 1997, Pages 153-157

  Massillon, Duna ^a   Barzilai, Nir ^a   Hawkins, Meredith ^a   Prus Wertheimer, Dina ^a   Rossetti, Luciano ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; ENZYME ACTIVITY; GENE EXPRESSION; GLUCONEOGENESIS; HYPERLIPIDEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031031276     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.1.153     Document Type: Article

References (41)

1. Nordlie RC, Bode AM, Foster JD: Recent advances in hepatic glucose-6-phosphatase regulation and function. Proc Soc Exp Biol Med 203:274-285, 1993
2. Mithieux G, Bordeto J-C, Minassian C, Ajzannay A, Mercier I, Riou JP: Characteristics and specificity of the inhibition of liver glucose-6-phosphatase by arachidonic acid: lesser inhibitability of the enzyme in diabetic rats. Eur J Biochem 213:461-466, 1993
3. Coleman RA, Rao P, Fogelsong RJ, Bardes ES: 2-Bromopalmitoyl-CoA and 2-bromopalmitate: promiscuous inhibitors of membrane-bound enzymes. Biochim Biophys Acta 1125:203-209, 1992
4. Fulceri R, Gamberucci A, Scott HM, Giunti R, Burchell A, Benedetti A: Fatty acyl-CoA esters inhibit glucose-6-phosphatase in rat liver microsomes. Biochem J 307:391-397, 1995
5. Mithieux G, Zitoun C: Mechanisms by which fatty-acyl-CoA esters inhibit or activate glucose-6-phosphatase in intact and detergent-treated rat liver microsomes. Eur J Biochem 235:799-803, 1996
6. Garg ML, Sabine JB, Snoswell AM: A comparison of the influence of diets high in saturated versus unsaturated fatty acids on lipid composition and glucose-6-phosphatase activity of rat liver microsomes. Biochem Int 10:585-595, 1985
7. Randle PJ, Garland PB, Hales CN, Newsolme EA: The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
8. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acids induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
9. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA: Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747, 1983
10. Saloranta C, Koivisto V, Widen E, Falholt K, DeFronzo RA, Harkonen M, Groop L: Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 264:E599-E605, 1993
11. Corkey BE, Glennon MC, Chen KS, Deeney JT, Matschinsky FM, Prentki M: A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic B-cells. J Biol Chem 264:21608-21612, 1989
12. Clore JN, Nestler JE, Blackard WG: Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans: putative signaling mechanism linking peripheral and hepatic events. Diabetes 38:285-290, 1989
13. Cohen N, Halberstam M, Rossetti L, Shamoon H: Increased lipid oxidation but normal muscle glycogen response to epinephrine in humans with IDDM. Am J Physiol 271:E284-E293, 1996
14. Reaven GM, Hollembeck C, Jeng C-Y, Wu MS, Chen Y-D: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024, 1988
15. Gonzales-Manchon C, Ayuso M, Parrilla R: Control of hepatic gluconeogenesis: role of fatty acid oxidation. Arch Biochem Biophys 271:1-9, 1989
16. Kim Y, Iwashita S, Tamura T, Tokuyama K, Suzuki M: Effect of high-fat diet on the gene expression of pancreatic GLUT2 and glucokinase in rats. Biochem Biophys Res Commun 208:1092-1098, 1995
17. Grimaldi PA, Knobel SM, Whitesell RR, Abumurad NA: Induction of aP2 gene expression by nonmetabolized long-chain fatty acids. Proc Natl Acad Sci USA 89:10930-10934, 1992
18. Chatelain F, Kohl C, Esser V, McGarry JD, Girard J, Pegorier J-P: Cyclic AMP and fatty acids increase carnitine palmitoyltransferase 1 gene transcription in cultured fetal rat hepatocytes. Eur J Biochem 235:789-798, 1996
19. Antras-Ferry J, Robin P, Robin D, Forest C: Fatty acids and fibrates are potent inducers of transcription of the phosphoenolpyruvate carboxykinase gene in adipocytes. Eur J Biochem 234:390-396, 1995
20. Jump DB, Clarke SD, Thelen A, Liimatta M: Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J Lipid Res 35:1076-1084, 1994
21. Mithieux G, Vidal H, Zitoun C, Bruni N, Danile N, Minassian C: Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes 45:891-896, 1996
22. Liu Z, Barrett EJ, Dalkin AC, Zwart AD, Chou JY: Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level. Biochem Biophys Res Commun 205:680-686, 1994
23. Haber BA, Chin S, Chuang E, Buikhuisen W, Naji A, Taub R: High levels of glucose-6-phosphatase expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest 95:832-841, 1995
24. Barzilai N, Rossetti L: Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem 268:25019-25025, 1993
25. Rosebrough RW, Begin JJ: The effect of non-protein energy sources on the ability of the chick to synthesize glucose-6-phosphatase. Poult Sci 55:1031-1035, 1976
26. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA: Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515, 1987
27. Rossetti L, Giaccari A: Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85:1785-1792, 1990
28. Rossetti L, Hu M: Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-induced inhibition of hepatic glucose production. J Clin Invest 92:2963-2974, 1993
29. Rossetti L, Giaccari A, Barzilai N, Howard K, Sebel G, Hu M: Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats: implications for the pathophysiology of fasting hyperglycemia. J Clin Invest 92:1126-1134, 1993
30. Farrace S, Rossetti L: Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats. Diabetes 41:1453-1463, 1992
31. 2+ concentrations. J Biol Chem 264:6033-6036, 1989
32. Massillon D, Barzilai N, Chen W, Hu M, Rossetti L: Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 271:9871-9874, 1996
33. Lange AJ, Argaud D, El-Maghrabi MR, Pan W, Maitra SR, Pilkis SJ: Isolation of a cDNA for the catalytic subunit of the rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. Biochem Biophys Res Commun 201:302-309, 1994
34. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH: Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40:1397-1403, 1991
35. Clore JN, Helm ST, Blackard WG: Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. J Clin Invest 96:1967-1972, 1995
36. Srivastava RA: Saturated fatty acid, but not cholesterol, regulates apolipoprotein A1 gene expression by posttranscriptional mechanism. Biochem Mol Biol Int 34:393-402, 1994
37. Rodriguez JC, Gil-Gomez G, Hegardt FG, Haro D: Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J Biol Chem 269:18767-18772, 1994
38. Khan A, Hong-Lie C, Landau BR: Glucose-6-phosphatase activity in islets from ob/ob and lean mice and the effect of dexamethasone. Endocrinology 136:1934-1938, 1995
39. Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI: Evolution of B-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447-1457, 1995
40. McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770, 1992
41. Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 44:863-870, 1995